Septicemia due to Staphylococcus aureus is often the consequence of a local infection (e.g. from catheters) which has gained access to the bloodstream. Once the bacteria is in the bloodstream, patients are at risk of developing endocarditis and other metastatic complications. One intriguing aspect in the pathogenesis of S. aureus infection is the ability of the microorganism to adhere to catheters and subsequently to the endothelium during transient bacteremia. Recent studies from this laboratory have suggested that S.aureus colonizes catheters and the endothelium by using a fibrinogen binding protein (FBP) to mediate adhesion to fibrinogen bound on respective surfaces. Our data have also shown that inflammatory mediators such as tumor necrosis factor can significantly augment the adherence of S.aureus to cultured human endothelial cells by promoting fibrinogen binding to the endothelium. To test the hypothesis that FBP is an important adhesin to both catheters and endothelium and to elucidate the mechanism of adherence, the structural gene for FBP in a selected strain will be expressed and sequenced. The cloned FBP will be purified and used to raise polyclonal and monoclonal antibodies. These antibodies mill be used to map out the fibrinogen binding domain of the adhesin (i.e. FBP). In addition, they will be tested in adherence assays with catheters and endothelium in both normal and cytokine-stimulated conditions. Further analysis of the FBP will be achieved by the construction of FBP deletion mutants lacking the fibrinogen binding phenotype by allele replacement. The mutants will be tested in staphylococcal adherence assays with catheters and cytokine-stimulated endothelium. The information generated from in vitro adherence studies will be applied to an in-vivo rabbit model of experimental endocarditis to determine if FBP plays a major role in mediating S.aureus adherence to heart valves during staphylococcal bacteremia. These proposed studies will enable us to determine if FBP is an important mediator of staphylococcal adherence to catheters and endothelium in both in vitro and in vivo settings. Since bacterial adherence always precedes tissue invasion, this knowledge would allow one to gain insights into devising strategies towards prevention of staphylococcal adherence to catheters, heart valves and other intravascular targets.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI030061-05
Application #
2442479
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1993-07-01
Project End
1999-06-30
Budget Start
1997-07-01
Budget End
1999-06-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Other Basic Sciences
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Guina, Tina; Lanning, Lynda L; Omland, Kristian S et al. (2018) The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule. Front Cell Infect Microbiol 8:99
Stark, Gregory V; Long, James P; Ortiz, Diana I et al. (2013) Clinical profiles associated with influenza disease in the ferret model. PLoS One 8:e58337
Leffel, Elizabeth K; Bourdage, James S; Williamson, E Diane et al. (2012) Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax. Clin Vaccine Immunol 19:1158-64
Vela, Eric M; Buccellato, Mathew A; Tordoff, Kevin et al. (2012) Efficacy of a heterologous vaccine and adjuvant in ferrets challenged with influenza virus H5N1. Influenza Other Respir Viruses 6:328-40
Fay, Michael P; Follmann, Dean A; Lynn, Freyja et al. (2012) Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge. Sci Transl Med 4:151ra126
Henning, Lisa N; Comer, Jason E; Stark, Gregory V et al. (2012) Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques. Clin Vaccine Immunol 19:1765-75
Comer, Jason E; Ray, Bryan D; Henning, Lisa N et al. (2012) Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment. Clin Vaccine Immunol 19:1517-25
Ngundi, Miriam M; Meade, Bruce D; Lin, Tsai-Lien et al. (2010) Comparison of three anthrax toxin neutralization assays. Clin Vaccine Immunol 17:895-903
Omland, Kristian S; Brys, April; Lansky, David et al. (2008) Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species. Clin Vaccine Immunol 15:946-53
Karl, Julie A; Wiseman, Roger W; Campbell, Kevin J et al. (2008) Identification of MHC class I sequences in Chinese-origin rhesus macaques. Immunogenetics 60:37-46

Showing the most recent 10 out of 32 publications